Discover B2B companies, suppliers, and manufacturers related to this keyword category
Making comprehensive liquid biopsy a reality
Delivering greater cfDNA, cfRNA and CTC yields for higher liquid biopsy test sensitivity and earlier cancer detection
Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Part of Exact Sciences.
Democratizing Data-Driven Medicine, Together!
Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in liquid biopsy
Best-in-Class Quality Controls and Reference Materials for Molecular Testing
Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine.
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic testing solutions.
We make ultrasensitive sequencing easy, enabling better solutions for healthcare, research, and industry